HM2017-39 Phase III Randomized Study of Crenolanib versus Midostaurin Administered FollowingInduction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 MutatedAcute Myeloid Leukemia

  • Warlick, Erica D (PI)

Project: Research project

Project Details

Description

HM2017-39 Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
StatusActive
Effective start/end date12/1/17 → 11/30/23

Funding

  • AROG PHARMACEUTICALS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint